Tag Archives: Benzodiazepine APIs Market

The market for Benzodiazepine APIs (Active Pharmaceutical Ingredients) is anticipated to expand at a CAGR of 3.5% between 2023 and 2031. Benzodiazepines are a class of psychoactive drugs used predominantly for their anxiolytic, sedative, hypnotic, and muscle-relaxing effects. Several factors drive the market for Benzodiazepine APIs, including the rising prevalence of anxiety disorders and insomnia, the expanding geriatric population, and ...